Chiron Real Estate Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Chiron Real Estate Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $148.21M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $138.78M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $141.05M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $137.28M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $115.94M | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $24.93M | Mar 8, 2021 |
| FY2020 | Sep 30, 2020 | $25.10M | Mar 8, 2021 |
| FY2020 | Jun 30, 2020 | $22.06M | Mar 8, 2021 |
| FY2020 | Mar 31, 2020 | $21.65M | Mar 8, 2021 |
| FY2020 | Dec 31, 2019 | $20.45M | Mar 8, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $18.34M | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | $2.59M | Mar 8, 2021 |
| FY2020 | Sep 30, 2020 | ($9.58M) | Mar 8, 2021 |
| FY2020 | Jun 30, 2020 | $1.67M | Mar 8, 2021 |
| FY2020 | Mar 31, 2020 | $2.82M | Mar 8, 2021 |
| FY2020 | Dec 31, 2019 | $2.78M | Mar 8, 2021 |
| FY2020 | Sep 30, 2019 | $2.31M | Mar 8, 2021 |
| FY2020 | Jun 30, 2019 | $2.46M | Mar 8, 2021 |
| FY2020 | Mar 31, 2019 | $2.04M | Mar 8, 2021 |
| FY2019 | Dec 31, 2018 | $9.50M | Mar 9, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $73.61M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $70.05M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $68.44M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $76.54M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $68.97M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $34.52M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $36.43M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $24.83M | Mar 8, 2021 |
| FY2019 | Dec 31, 2017 | $12.60M | Mar 9, 2020 |
| FY2018 | Dec 31, 2016 | ($2.17M) | Mar 11, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $31.76M | Jun 28, 2016 |
| FY2015 | Dec 31, 2014 | $2.51M | Jun 28, 2016 |
| FY2015 | Aug 31, 2014 | $21.87M | Jun 28, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.24B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.26B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.27B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.39B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.26B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.10B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $884.93M | Mar 8, 2021 |
| FY2019 | Dec 31, 2018 | $636.10M | Mar 9, 2020 |
| FY2018 | Dec 31, 2017 | $471.82M | Mar 11, 2019 |
| FY2017 | Dec 31, 2016 | $227.32M | Mar 12, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $712.40M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $700.57M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $661.89M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $744.20M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $625.91M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $643.15M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $424.58M | Mar 8, 2021 |
| FY2019 | Dec 31, 2018 | $336.35M | Mar 9, 2020 |
| FY2018 | Dec 31, 2017 | $212.81M | Mar 11, 2019 |
| FY2017 | Dec 31, 2016 | $72.29M | Mar 12, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $509.77M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $534.13M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $583.58M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $632.98M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $622.79M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $444.81M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $430.27M | Mar 8, 2021 |
| FY2019 | Dec 31, 2018 | $269.30M | Mar 9, 2020 |
| FY2018 | Dec 31, 2017 | $246.34M | Mar 11, 2019 |
| FY2017 | Dec 31, 2016 | $155.03M | Mar 12, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.90M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $5.90M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $5.90M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $5.90M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $5.90M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $5.90M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Mar 8, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($349.97M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($293.74M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($238.98M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($198.71M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | ($157.02M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($116.77M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($71.39M) | Mar 8, 2021 |
| FY2019 | Dec 31, 2018 | ($45.01M) | Mar 9, 2020 |
| FY2018 | Dec 31, 2017 | ($34.43M) | Mar 11, 2019 |
| FY2015 | Dec 31, 2015 | ($3.15M) | Mar 21, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.08M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $6.82M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.28M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.02M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $7.21M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $5.51M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $2.77M | Mar 8, 2021 |
| FY2019 | Dec 31, 2018 | $3.63M | Mar 9, 2020 |
| FY2018 | Dec 31, 2017 | $5.11M | Mar 11, 2019 |
| FY2017 | Dec 31, 2016 | $19.67M | Mar 12, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.15M | Mar 2, 2026 |
| FY2024 | Dec 31, 2024 | $14.42M | Feb 28, 2025 |
| FY2015 | Aug 31, 2014 | $15.06M | Jun 28, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 1, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 1, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13.23M | Mar 2, 2026 |
| FY2025 | Sep 19, 2025 | 13.41M | Mar 2, 2026 |
| FY2025 | Sep 18, 2025 | 67.04M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 13.37M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 65.57M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 65.52M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 64.88M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 49.46M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 43.81M | Mar 8, 2021 |
| FY2019 | Dec 31, 2018 | 25.94M | Mar 9, 2020 |